Breaking News
Top News
-
AI Absorbs $242 Billion in Q1 Venture Funding, Exceeding All of 2025 Combined
-
Cramer Highlights Nike, Amazon, Nvidia Stock To Investors: ‘Why Would You Sell It?’
-
Silver Is Outperforming Gold in 2026. Does SLV Deserve a Spot in Your Portfolio?
-
Downsizing? Here’s how to make sure you don’t get dinged with a Medicare premium surcharge
-
1 No-Brainer Growth Stock to Buy With $30 Right Now
-
Latest acquisition by Brad Jacobs’ QXO building products rollup is largest so far
-
If Netflix Can Keep Winning on This Key Metric, the Stock Could Soar
-
Dow Jones Futures Fall, Oil Prices Jump; Trump Announces New Iran Talks With Hormuz Shut
-
Will the DHS shutdown affect security for the World Cup?
-
Pro-Russia ex-president claims victory in Bulgaria’s elections
-
Bourbon Hangover Hits 2 More Kentucky Distilleries
-
Top 5 Canadian Mining Stocks This Week: Tincorp Metals Pops 128 Percent
-
Here’s What Piper Sandler Thinks About Boston Scientific Corp (BSX) Now
-
What Makes Veeva Systems Inc (VEEV)’s Future Bright?
-
Favorable Zio Results Brighten iRhythm Holdings, Inc (IRTC)’s Prospects
-
Here’s What TD Cowen Thinks About Tempus AI Inc (TEM) Stock
-
Teladoc Health Inc (TDOC): AI Push Amid Share BuyBack Calls
-
Here is Why Lantheus Holdings Inc (LNTH) Is Among the Best Medical AI Stocks to Invest In
-
Butterfly Network Inc (BFLY): Top Medical AI Stock to Buy
-
Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership
2026-02-05



















